SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211055
Filing Date
2013-05-09
Accepted
2013-05-09 16:17:27
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d505256d10q.htm 10-Q 439321
2 EX-31.1 d505256dex311.htm EX-31.1 9863
3 EX-31.2 d505256dex312.htm EX-31.2 10215
4 EX-32.1 d505256dex321.htm EX-32.1 5945
11 GRAPHIC g505256g13e53.jpg GRAPHIC 1194
  Complete submission text file 0001193125-13-211055.txt   2667756

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snss-20130331.xml EX-101.INS 324491
6 XBRL TAXONOMY EXTENSION SCHEMA snss-20130331.xsd EX-101.SCH 27157
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20130331_cal.xml EX-101.CAL 45052
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20130331_def.xml EX-101.DEF 92170
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20130331_lab.xml EX-101.LAB 208511
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20130331_pre.xml EX-101.PRE 146614
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 13829120
SIC: 2834 Pharmaceutical Preparations